Max Healthcare Institute Ltd Q3 FY2025 Concall Summary

Key Takeaways

• 30%+ YoY growth across the board: Revenue, EBITDA and occupied bed days all grew over 30% YoY, with recent acquisitions adding momentum.
• Dwarka hits EBITDA breakeven in 6 months: The greenfield hospital broke even in December 2024, a record pace, and every incremental bed now drops ~52% of revenue to the bottom line.
• Brownfield capacity wave is imminent: Significant bed additions across Nanavati, Saket, Mohali and Lucknow are due within the next six months, setting up a period of operating leverage.
• Balance sheet is deliberately under-levered: Net debt-to-EBITDA sits at 0.65x against a self-imposed 2.5x ceiling, leaving ample room for the committed capex and any inorganic moves.
• What to watch next quarter: The pace of brownfield bed commissioning, the CGHS rate revision outcome, and whether the incremental margin from Dwarka’s new beds materialises as guided.

Brownfield Expansion & Operating Leverage

• Capacity coming online within six months: Nanavati Phase 1 (268 beds) completes in 3–4 months, Max Smart Saket (400 beds) and Mohali (155 beds) by Q1 FY26, and Lucknow just added 128 beds with approval sought for another 140.
• Institutional business is a deliberate ramp tool: New hospitals start with institutional patients to fill beds and cover fixed costs; even at lower rates, EBITDA per bed rises because brownfield additions spread existing overhead across more occupied beds.
• Nagpur illustrates the leverage math: At 79% occupancy in a seasonally weak quarter, Nagpur delivered ~20% EBITDA margin; management says even a 5% occupancy increase over two years will fill the facility, and the target ROCE is 20–25% within four years.
• Dwarka’s incremental bed economics are now proven: With contribution at 60% and incremental cost at 8–9%, roughly 52% of every new bed’s revenue flows to EBITDA; this will be demonstrated over the next few quarters.
• Nanavati margin uplift is structural: The combination of 50–60% more capacity defraying the same cost base, plus right-sizing of low-demand ward beds, means margins will certainly rise once Phase 2 is complete.

Abhay Soi: "If your contribution is 60%, you take out 8% from that. So, 52% of your top line is going straight to your bottom line."

Asset-Light Growth & Capital Allocation

• Thane and Mohali are build-to-suit deals: Partners incur 80% of the capital cost (land and building), locked in at an 8–9% yield, while Max enjoys a 35% stable-state ROCE on the whole hospital, pushing its effective ROCE beyond 100%.
• Thane structure includes a call option: After 12 months of operations, Max can acquire the 500-bed hospital at cost, with commissioning expected in 2028.
• Mohali capacity doubled before construction: The board approved increasing the upcoming Zirakpur hospital to 400 beds from 250, with completion within 30 months.
• Capex is front-loaded but funded: ₹500–600 crore will be spent over the next 3–4 months on brownfields, all within the existing debt framework.
• Debt ceiling is self-imposed and distant: Management’s upper limit is 2.5x net debt-to-EBITDA; the current 0.65x leaves headroom for both committed capex and further inorganic growth.

Abhay Soi: "Our upper limit is 2.5x net debt-to-EBITDA, but we are far from that."

Payor Mix & Pricing Dynamics

• Institutional ARPOB gap is narrowing: The discount to cash rates has shrunk from 44% to 36%, driven by a richer oncology mix rather than rate increases on the institutional side.
• CGHS rate revision is expected soon: Management anticipates a revision within a month or two, which would also lift other PSU business rates.
• Insurance pricing faces no downward pressure: Medical inflation runs 6–7% annually, and 5–6% pricing growth every two years is described as non-disputable; the IRDAI senior citizen cap is seen as a benefit because fewer policyholders will drop coverage due to premium step-ups.
• Payor mix is not directly controllable: The burden of disease drives clinical mix; management focuses on moving toward higher-technology programs, robotics and deeper international engagement, with international revenue up 28% YoY despite political headwinds in Bangladesh and Yemen.

Abhay Soi: "5-6% growth in pricing every two years is not something that you can dispute, right? How much lower do you want to be is the question."

Unit-Level Performance & Seasonality

• Existing units held flat QoQ despite festivals: Q3 is typically a weak quarter with 2–3% revenue and 3–4% EBITDA sequential drops, but this quarter revenue was flat and EBITDA improved because Diwali fell at the very end of the month.
• Lucknow delivered breakout growth: Revenue up 58% YoY and EBITDA up 94% in Q3, with a radiation oncology bunker coming online in July that should lift oncology revenue considerably.
• Nagpur grew 22% YoY on revenue and 50% on EBITDA: The QoQ occupancy decline from 91% to 79% is seasonal, driven by a high incidence of vector-borne disease in Q2; 79% is not considered low for a slow season.
• Jaypee contributed ₹112 crore gross revenue at 21% margin: Now a wholly-owned subsidiary, its integration is underway and the margin profile is already meaningful.
• PHF profitability dip is structural, not operational: Two PHFs revised their fee structures, upstreaming ~₹25 crore annually in PBT to MHIL; a ₹40 crore donation between societies was recorded as an elimination and has no bearing on tax status.

Market Position & Competitive Moat

• Delhi NCR density is unmatched: Max operates 15 facilities in Delhi NCR, twice the number of the next three listed players combined, and the next 20 players are not even the same size.
• Brownfield strategy compounds the advantage: Adding capacity onto existing hospitals captures operating leverage that greenfields cannot match, while the institutional ramp playbook has been proven at Shalimar Bagh and Nagpur.
• International business is diversifying the base: 28% YoY growth came from deeper geographic engagement even as patient footfalls from Bangladesh and Yemen contracted; upcountry NCR now contributes 40% of the region’s business and is growing faster.

Abhay Soi: "Today, we have 15 facilities in Delhi NCR, which are twice the number of facilities of the next three listed players put together. So, literally three players put together and the next 20 players are not even the same size."

Guidance & Commitments

Key Metrics